BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
May 24, 2006
View Archived Issues
U3 Pharma Raises EUR 27M For Preclinical Cancer Products
U3 Pharma AG raised €27 million (US$34.7 million) to accelerate development of its pipeline of targeted therapies, designed to modulate signal transduction pathways in cancer. (BioWorld International)
Read More
Vaccine Awards To Come, But Patent Issues Remain
Read More
Rare Inherited Skin Tumor Points To Oncogene Control Mechanism
Read More
Further Labeling Controls Foreseen For EU GM Crops
Read More
MorphoSys Adds As Partner For HuCal Schering-Plough
Read More
BioAlliance Starting Phase III Trial, Exploring Opportunities
Read More
New Irish Research Initiative Puts Focus On Universities
Read More
After Merger With Proteom, Amura Wants Deals, Money
Read More
Other News To Note
Read More